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Extreme sensitivity of myelinating optic nerve axons  
in a rodent model of perinatal ischemic injury 
Objectives and Principal findings 
 Developing central white matter is subject to ischemic-type injury during the period that 
precedes myelination. At this stage in maturation, axons initiate a programme of ion channel re-
distribution.  
 Here we test the hypothesis that during radial expansion axons display heightened ischemic 
sensitivity, when clusters of Ca2+ channels decorate future node of Ranvier sites. 
 Our results show that this axon population is more sensitive to ischemia than neighbouring 
myelinated axons and to smaller axons yet to initiate radial expansion. Injury is mediated by Ca2+ 
influx through Ca2+ channels expressed in axolemma clusters.  
 A pharmacological strategy designed to protect both small and large diameter pre-myelinated 
axons proved 100% protective against acute ischemia studied under modelled ischemia in vitro. 
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Introduction 
 Cerebral white matter injury (WMI) is increasingly recognized as a common form of perinatal 
brain injury that predisposes to cerebral palsy as well as cognitive and learning disabilities. 
 Despite the growing impact of WMI, it is unclear whether common cellular and molecular 
mechanisms define WMI pathogenesis in preterm and term neonates. 
 Although numerous studies have defined a role for glial vulnerability in WMI, there has been 
limited study of the susceptibility of immature axons. 
Methods and Results 
Maturation-dependent axonal vulnerability in the optic nerve 
 We compared the magnitude of axonal damage at post-natal day 10 (P10), 20 (P20) and adult 
Thy-1/GFP-M mice optic nerves, using confocal microscopy.  Pathological changes including local 
swelling, axonal beading and fragmentation were observed (Fig 1 C-E). 
 Consistent with earlier studies1, there is heightened sensitivity to ischemic conditions in axons of 
the P20 optic nerve. 
 Electron microscopy revealed generalized areas of axonal swelling with dissolution of axoplasmic 
inclusions. Less damaged axons showed localized regions of sub-myelin swelling where the 
sheath occasionally buckled from the axolemma and formed vesicular debris (Fig 1 A) 
Axons preparing for myelination have a heightened sensitivity to OGD 
 Ultra-micrograph morphometric analysis of wild-type P20 MON revealed populations of 
premyelinated (0.10-0.56 µm), ensheathed (0.35-0.73 µm) and myelinated (0.54-2.20 µm) axons 
(Fig 2 A-D). 
 A range of GFP-M(+) axon diameters were observed in Thy-1/GFP-M mice of the same age over 
the range 0.43-1.90 µm (Fig 2 E, F).  Therefore our model allows imaging of large pre-
myelinating, ensheathed and myelinated axons but not small pre-myelinating axons.   
 Following a standard 60 min OGD + 60 min recovery protocol applied to the transgenic P20 
MON, injury scoring revealed an inverse relationship between axon pathology and diameter, 
with the large pre-myelinated axons damaged most and injury tailing off as axons progressed 
through ensheathment and myelination (Fig 2G).  
Block of intracellular Ca2+ release does not protect P10 RON axons 
 Developing RON axons contain numerous inclusions that are potential intracellular Ca2+ stores 
(Fig 3 A).   
 The addition of neither thapsigargin (a sarco/endoplasmic reticulum Ca2+-ATPase pump 
inhibitor) nor diltiazem (an L-type VGCC blocker) increased the protection against OGD-induced 
injury from that seen in zero Ca2+ alone (Fig 3 B – E).   
Combined block of glutamate receptors and voltage gated calcium channels is 
highly protective against degeneration of premyelinated axons 
 Electrophysiology recordings of compound action potential (CAP) across optic nerves showed that 
the combined action of VGCC blockers  and GluR blockers  resulted in complete recovery from 60 
min of OGD (Fig 4 A).  
 Immuno-staining of axons for either neurofilament light (NF-L) or heavy (NF-H) corroborated this 
finding (Fig 4 B). 
 Ultrastructural analysis further proved that addition of VGCC block to GluR block augmented 
protection to include the larger pre-myelinated axons (Fig 4 C-G).  
Combined block of glutamate receptors and voltage gated calcium channels 
protected larger pre-myelinated axons. 
 Examination of microtubule numbers in cross section electron micrographs showed that in small 
diameter (< 0.4 µm) axons microtubule disassembly was prevented following OGD by GluR block 
and by “all treatments” (Fig 5 A).  
 On the other hand microtubules in larger diameter (> 0.4 µm) pre-myelinated axons were not 
protected from OGD by GluR block but were by “all treatments” (Fig 5 A), consistent with a role 
for VGCC in damage to this axon group.  
 OGD resulted in a significant reduction in the number of tubules in axons of all diameters.  GluR 
block prevented tubule loss following OGD only in axons <0.4 µm, whilst the addition of VGCC 
provided protection also to the larger pre-myelinating axons. Fig 4 B) 
Conclusion 
 By imaging GFP-M expression that was restricted to pre-myelinated, ensheathed and early 
myelinated axons, we found highly selective injury of the smallest fluorescent axons. These 
corresponded to the larger pre-myelinated axons.  
 We found no evidence for a contribution from intracellular Ca2+ release to ischemic axon injury at 
this developmental stage.  
 Prior to the onset of myelination, axons initiate radial expansion and undergo ion channel re-
organization in preparation for the formation of nodes of Ranvier and myelination. The 
appearance of P/Q- and L-type voltage-gated VGCC clusters at putative node sites is an early event 
in this process2, and our results indicate that these VGCCs act as a significant route of toxic Ca2+ 
influx during hypoxia-ischemia, making axons more vulnerable to ischemic injury than at any other 
point in their maturation 
Clinical Relevance 
 Early maturing axons having initiated diameter expansion and expressing clusters of functional 
VGCC, are exquisitely sensitive to ischemic injury. This is a property that this axon population 
shares with preOLs, previously regarded as the most ischemia-sensitive element with immature 
white matter.   By contrast, axons yet to enter this developmental window, or which have passed 
through it to initiate myelination, have a much higher ischemic tolerance.  
 Recent clinical data highlight the importance of axon pathology in developing white matter injury. 
The elevated susceptibility of early maturing axons to ischemic injury described here may 
significantly contribute to selective white matter pathology and places these axons alongside pre-
oligodendrocytes as a potential primary target of both injury and therapeutics  
 Since human white matter begins active myelinating in the third trimester3, the VGCC-mediated 
axonal injury identified here may contribute to WMI from late mid-term into the post-natal period 
and following milder insults not characterized by necrosis. 
 The high degree of protection afforded to larger pre-myelinated axons by the multiple agent 
pharmacological strategy tested here suggests a strategy to reduce preterm WMI during the 
transition to active myelination, although detailed testing with in vivo models is first required. 
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Figure 1: OGD-induced injury in rodent axons 
 
A: Ultra-micrograph from post-OGD  RON, 
showing regional myelin detachment from the 
axoplasm, shown in cross section in “B”. “Ax” = 
myelinated axon.  Bar = 100 nm.  
 
C-E Pathological changes in GFP-M axons in 
mice at P10 , P20  and adult  exposed to 60 
min OGD + 60 min recovery. Boxed regions are 
expanded below. Bar = 10 µm.  
 
F: The mean axon injury score of GFP-M axons 
collected after 30, 60, 90 or 120 min of OGD . 
Data collected from P10 (red), P20 (blue) and 
adult (green) MONs is included. Axon injury in 
P20 MONs is higher under all conditions than 
at P10 or adult. 
 
Figure 2: Central axons preparing for myelination 
have a heightened sensitivity to OGD.  
 
A: Electron micrograph of wild-type P20 MON 
showing pre-myelinated axons (arrows), ensheathed 
axons (arrow heads) and early myelinated axons 
(“myl”) in cross section. Bar = 1 µm 
 
 B-D: Diameter spectra for pre-myelinated axon (B), 
ensheathed axons (C) and myelinated axons (D).  
 
E: GFP-M fluorescent axons in transgenic P20 MO. 
Bar = 5 µm.  
 
F: Diameter spectrum of fluorescent axons.  
 
G: Injury scores for fluorescent axons following 60 
min OGD + 60 min recovery, plotted against axon 
diameter. Note that the smallest fluorescent axons 
corresponding to large pre-myelinated and 
enstheathed axons, are the most damaged. 
 
Figure 4: Combined GluR and VGCC block is highly protective of all 
premyelinated axons 
 
A: In the presence of ω-agatoxin VIA+diltiazem+MK-801+NBQX (“All 
treatments”) CAP area recovered fully from a 60 min period of OGD. Bars = 
2 mV/ 1 msec. 
  
B: Electron-micrograph showing typical ultrastructural changes following 
the OGD protocol in the absence of drugs. Larger diameter ensheathed 
axons (arrow head) has lost all microtubules. Bar = 0.5 µm.  
 
C: NF-L and NF-H staining was also protected during OGD by the “all 
treatments” protocol.  
 
D, E: The ultrastructural features of axons in nerves exposed to 60 min OGD 
and recovery in the presence of ‘all treatment’. Even large pre-myelinated 
axons retain membrane integrity and contain microtubules (arrows). 
Myelinated axons (“Ax”) retain membrane integrity but have few 
microtubules and exhibit myelin pathology. Bar = 1 µm. 
 
F: Axon health was assessed using (axon viability score), where a score of 
3represents a normal appearance and 0 represents total axon breakdown 
 
G: Mean viability score in treated RONs for small (<0.4µm diameter, black 
bars) and large (>0.4µm diameter, white bars) pre-myelinated axon does 
not differ significantly from control. 
 
Figure 5: Addition of VGCC block to GluR block protected larger pre-myelinated 
axons 
 
A: Microtubule number in small axons (<0.4 µm) falls significantly following OGD, 
an effect that is countered by GluR block; this effect is not augmented by 
combined GluR + VGCC block (“All treatments”). Microtubule number in larger 
axons (>0.4 µm) falls significantly following OGD, an effect that is not reduced by 
GluR block but is prevented by combined GluR and VGCC block.  
 
B: Mean microtubule number plotted against axon diameter (0.05 µm bins) for 
pre-myelinated axons. Note that OGD produces a significant reduction in the 
number of microtubules at any given axon diameter while GluR block protects 
the smaller axons and “all treatments” prevents the loss of microtubules across 
the whole diameter spectrum (“*” = P<0.05 vs., control). 
Figure 3: Central axons preparing for myelination 
have a heightened sensitivity to OGD.  
 
A: High-power electron micrograph showing the 
presence of intracellular inclusions with the features 
of endoplasmic reticulum in premyelinated and 
actively myelinating axons (e.g., arrows).  
 
B- D: CAPs recorded from a RON that was exposed to 
zero Ca2+/50 µM EGTA, plus thapsigargin (B-C), and 
diltiazem (D) 
 
 E: Data summary showing that neither thapsigargin 
protocol nor diltiazem significantly increased the 
degree of recovery compared to the relevant control. 
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